Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 379

recruiting
3 974
countries
28
conditions
2 109

10 386 trials match your criteria

Systemic scleroderma

Not yet recruiting

Rituximab versus placebo for maintenance therapy in adults with stabilized systemic sclerosis‑associated interstitial lung disease

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Microdosing lysergide (20 µg) to improve symptoms, emotion regulation and sleep in adults with ADHD

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Lysergide

Systemic scleroderma

Not yet recruiting

Lebrikizumab in Adults with Moderate to Severe Localized Scleroderma

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years

Neoplasm+2

Not yet recruiting

REGN10597 Alone or with Cemiplimab in Adults with Advanced Solid Tumours, Melanoma, or Clear-Cell Renal-Cell Carcinoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Colon cancer

Not yet recruiting

Pembrolizumab for Patients with Localised dMMR Colon Cancer: Neoadjuvant and Organ-Sparing Treatment Study

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years

Pre-eclampsia

Not yet recruiting

Acetylsalicylic Acid for Preventing Preeclampsia in Pregnant Women

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Acetylsalicylic Acid

End stage renal disease

Not yet recruiting

OM336 for Desensitization in Patients with End-Stage Renal Failure Awaiting Kidney Transplantation

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Valaciclovir

Gastric cancer

Not yet recruiting

68Ga-FAPI-46 PET-CT for Initial Staging of Gastric Cancer in Patients Eligible for Curative Treatment

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Septic shock+1

Not yet recruiting

Angiotensin II in Children and Adolescents With Refractory Hypotension in Distributive Shock

Registered drug
Countries:FranceFrance
  • Participants:0–17 years

Coronary artery disease

Not yet recruiting

A study to evaluate the effect of EA-230 on the hospital stay length for patients undergoing coronary artery bypass surgery for coronary artery disease.

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years

Bacterial infection+1

Not yet recruiting

A study to evaluate the use of meropenem to reduce the risk of sepsis in patients with suspected infection in the emergency department

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.